29. Micromonospora Purpurea: Hospital Infection Fighter
Scientists isolated gentamicin from this bacterium in 1963. It targets bacterial ribosomes to treat serious gram-negative infections like sepsis. Hospital settings commonly use it for critically ill patients. The drug can damage hearing and kidneys, requiring careful monitoring during treatment. Researchers continue developing semi-synthetic analogs to reduce these side effects. Despite newer antibiotics, gentamicin remains valuable for combating resistant hospital-acquired infections.